Cooper Companies Inc
NYSE:COO
Cooper Companies Inc
NYSE:COO
Price:
98.31 USD
0.42%
Updated:
May 16, 2024
Cooper Companies Inc
Cost of Revenue
|
Cooper Companies Inc
Cost of Revenue Peer Comparison
Comparables:
HAE
XRAY
ALGN
LNTH
MMSI
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cooper Companies Inc
NYSE:COO
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cost of Revenue
-$591m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cost of Revenue
-$1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-22%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cost of Revenue
-$491.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-9%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cost of Revenue
-$686.1m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Cooper Companies Inc's Cost of Revenue?
Cost of Revenue
-1.2B
USD
-1.2B
USD
Based on the financial report for Jan 31, 2024, Cooper Companies Inc's Cost of Revenue amounts to -1.2B USD.
What is Cooper Companies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%
-8%
Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for Cooper Companies Inc have been -11% over the past three years , -7% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
